サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1387324

抗生物質耐性の世界市場：動向、予測、競合分析（～2030年）

Antibiotic Resistance Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

抗生物質耐性の世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月31日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

抗生物質耐性の動向と予測

世界の抗生物質耐性の市場規模は、2024～2030年にかけてCAGR 5.9%で成長し、2030年までに約122億米ドルに達すると予測されています。この市場の主な促進要因は、抗生物質の普及率の増加、新規治療法の開発に対する政府・非政府機関の関与の拡大です。世界の抗生物質耐性市場の将来は、病院薬局、小売薬局、オンライン薬局の各市場におけるビジネスチャンスで有望視されています。

抗生物質耐性市場の洞察

Lucintelは、cUTI（複雑性尿路感染症）は、強固な製品開発パイプラインの存在により、予測期間中最大のセグメントであり続けると予測しています。

この市場において、病院薬剤師は、薬剤処方の監督、耐性パターンの追跡、教育の実施、薬剤の安全性の保証において重要な役割を果たしているため、最大のセグメントであり続けるでしょう。

北米は、同地域における政府プログラムや強制保険政策の増加により、予測期間中も最大地域であり続けるでしょう。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがあるか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の抗生物質耐性市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の抗生物質耐性市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界の抗生物質耐性市場：疾患別
    • cUTI (Complicated Urinary Tract Infections)
    • CDI (Clostridioides difficile Infection)
    • ABSSSI (Acute bacterial skin and skin structure infections)
    • HABP (Hospital-acquired bacterial pneumonia)
    • CABP (Community-acquired pneumonia)
    • cIAI (Complicated intra-abdominal infection)
    • その他
  • 世界の抗生物質耐性市場：病原体別
    • E. Coli
    • K. Pneumoniae
    • P. Aeruginosa
    • S. Aureus
    • A. Baumannii
    • S. Pneumoniae
    • その他
  • 世界の抗生物質耐性市場：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 世界の抗生物質耐性市場：作用機序別
    • Protein Synthesis Inhibitors
    • Cell Wall Synthesis Inhibitors
    • RNA Synthesis Inhibitors
    • DNA Synthesis Inhibitors
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界の抗生物質耐性市場：地域別
  • 北米の抗生物質耐性市場
  • 欧州の抗生物質耐性市場
  • アジア太平洋の抗生物質耐性市場
  • その他の地域の抗生物質耐性市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 疾患別の世界の抗生物質耐性市場の成長機会
    • 病原体別の世界の抗生物質耐性市場の成長機会
    • 流通チャネル別の世界の抗生物質耐性市場の成長機会
    • 作用機序別の世界の抗生物質耐性市場の成長機会
    • 地域別の世界の抗生物質耐性市場の成長機会
  • 世界の抗生物質耐性市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の抗生物質耐性市場の生産能力拡大
    • 世界の抗生物質耐性市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Melinta
  • Basilea Pharmaceutical
  • Tetraphase Pharmaceuticals
  • Theravance Biopharma
  • WOCKHARDT
目次

Antibiotic Resistance Trends and Forecast

The future of the global antibiotic resistance market looks promising with opportunities in the hospital pharmacie, retail pharmacie and online pharmacie markets. The global antibiotic resistance market is expected to reach an estimated $12.2 billion by 2030 with a CAGR of 5.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of antibiotic and growing government and non-government bodies involvement in the development of novel therapies.

A more than 150-page report is developed to help in your business decisions.

Antibiotic Resistance by Segment

The study includes a forecast for the global antibiotic resistance by disease, pathogen, distribution channel, mechanism of action, and region.

Antibiotic Resistance Market by Disease [Shipment Analysis by Value from 2018 to 2030]:

  • cUTI (Complicated Urinary Tract Infections)
  • CDI (Clostridioides Difficile Infection)
  • ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
  • HABP (Hospital-Acquired Bacterial Pneumonia)
  • CABP (Community-Acquired Pneumonia)
  • cIAI (Complicated Intra-Abdominal Infection)
  • Others

Antibiotic Resistance Market by Pathogen [Shipment Analysis by Value from 2018 to 2030]:

  • E. Coli
  • K. Pneumoniae
  • P. Aeruginosa
  • S. Aureus
  • A. Baumannii
  • S. Pneumoniae
  • Others

Antibiotic Resistance Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Antibiotic Resistance Market by Mechanism of Action [Shipment Analysis by Value from 2018 to 2030]:

  • Protein Synthesis Inhibitors
  • Cell Wall Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • Others

Antibiotic Resistance Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Antibiotic Resistance Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies antibiotic resistance companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the antibiotic resistance companies profiled in this report include-

  • Melinta
  • Basilea Pharmaceutical
  • Tetraphase Pharmaceuticals
  • Theravance Biopharma
  • WOCKHARDT

Antibiotic Resistance Market Insights

Lucintel forecasts that cUTI (complicated urinary tract infection) will remain the largest segment over the forecast period due to existence of a robust product development pipeline.

Within this market, hospital pharmacie will remain the largest segment as it plays a vital role in overseeing drug formularies, tracking resistance patterns, delivering education, and guaranteeing medication safety.

North America will remain the largest region over the forecast period due to increasing number of government programs and mandatory insurance policies in the region.

Features of the Global Antibiotic Resistance Market

Market Size Estimates: Antibiotic resistance market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Antibiotic resistance market size by various segments, such as by disease, pathogen, distribution channel, mechanism of action, and region in terms of value ($B).

Regional Analysis: Antibiotic resistance market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diseases, pathogens, distribution channels, mechanism of actions, and regions for the antibiotic resistance market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the antibiotic resistance market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the antibiotic resistance market size?

Answer: The global antibiotic resistance market is expected to reach an estimated $12.2 billion by 2030.

Q2. What is the growth forecast for antibiotic resistance market?

Answer: The global antibiotic resistance market is expected to grow with a CAGR of 5.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the antibiotic resistance market?

Answer: The major drivers for this market are increasing prevalence of antibiotic and growing government and non-government bodies involvement in the development of novel therapies.

Q4. What are the major segments for antibiotic resistance market?

Answer: The future of the antibiotic resistance market looks promising with opportunities in the hospital pharmacie, retail pharmacie and online pharmacie markets.

Q5. Who are the key antibiotic resistance market companies?

Answer: Some of the key antibiotic resistance companies are as follows:

  • Melinta
  • Basilea Pharmaceutical
  • Tetraphase Pharmaceuticals
  • Theravance Biopharma
  • WOCKHARDT

Q6. Which antibiotic resistance market segment will be the largest in future?

Answer: Lucintel forecasts that cUTI (complicated urinary tract infection) will remain the largest segment over the forecast period due to existence of a robust product development pipeline.

Q7. In antibiotic resistance market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing number of government programs and mandatory insurance policies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the antibiotic resistance market by disease (cUTI (complicated urinary tract infections), CDI (clostridioides difficile infection), ABSSSI (acute bacterial skin and skin structure infections), HABP (hospital-acquired bacterial pneumonia), CABP (community-acquired pneumonia), CIAI (complicated intra-abdominal infection), and others), pathogen (e. coli, k. pneumoniae, p. aeruginosa, s. aureus, a. baumannii, s. pneumoniae, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), mechanism of action (protein synthesis inhibitors, cell wall synthesis inhibitors, rna synthesis inhibitors, dna synthesis inhibitors, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Antibiotic Resistance Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Antibiotic Resistance Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Antibiotic Resistance Market by Disease
    • 3.3.1: cUTI (Complicated Urinary Tract Infections)
    • 3.3.2: CDI (Clostridioides difficile Infection)
    • 3.3.3: ABSSSI (Acute bacterial skin and skin structure infections)
    • 3.3.4: HABP (Hospital-acquired bacterial pneumonia)
    • 3.3.5: CABP (Community-acquired pneumonia)
    • 3.3.6: cIAI (Complicated intra-abdominal infection)
    • 3.3.7: Others
  • 3.4: Global Antibiotic Resistance Market by Pathogen
    • 3.4.1: E. coli
    • 3.4.2: K. pneumoniae
    • 3.4.3: P. aeruginosa
    • 3.4.4: S. aureus
    • 3.4.5: A. baumannii
    • 3.4.6: S. pneumoniae
    • 3.4.7: Others
  • 3.5: Global Antibiotic Resistance Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Retail Pharmacies
    • 3.5.3: Online Pharmacies
  • 3.6: Global Antibiotic Resistance Market by Mechanism of Action
    • 3.6.1: Protein Synthesis Inhibitors
    • 3.6.2: Cell Wall Synthesis Inhibitors
    • 3.6.3: RNA Synthesis Inhibitors
    • 3.6.4: DNA Synthesis Inhibitors
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Antibiotic Resistance Market by Region
  • 4.2: North American Antibiotic Resistance Market
    • 4.2.2: North American Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.3: European Antibiotic Resistance Market
    • 4.3.1: European Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
    • 4.3.2: European Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.4: APAC Antibiotic Resistance Market
    • 4.4.1: APAC Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
    • 4.4.2: APAC Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.5: ROW Antibiotic Resistance Market
    • 4.5.1: ROW Antibiotic Resistance Market by Disease: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), and Others
    • 4.5.2: ROW Antibiotic Resistance Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Antibiotic Resistance Market by Disease
    • 6.1.2: Growth Opportunities for the Global Antibiotic Resistance Market by Pathogen
    • 6.1.3: Growth Opportunities for the Global Antibiotic Resistance Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Antibiotic Resistance Market by Mechanism of Action
    • 6.1.5: Growth Opportunities for the Global Antibiotic Resistance Market by Region
  • 6.2: Emerging Trends in the Global Antibiotic Resistance Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Antibiotic Resistance Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Antibiotic Resistance Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Melinta
  • 7.2: Basilea Pharmaceutical
  • 7.3: Tetraphase Pharmaceuticals
  • 7.4: Theravance Biopharma
  • 7.5: WOCKHARDT